Development of a Stereoselective Route for Kilogram-Scale Synthesis of STING Agonist BMS-986301

Abstract Following the discovery of a chiral P(V) reagent to enable diastereoselective synthesis of stereogenic thiophosphoramidates, we have developed a scalable synthesis to deliver kilogram quantities of the STING agonist BMS-986301. The route not only reduced the number of steps compared to the enabling route but also avoided the use of hazardous reagents. Further development enabled the use of crystallizations to isolate intermediates, effectively eliminating six chromatographic purifications. This resulted in an eightfold improvement in yield and 90% reduction in process mass intensity (PMI). The route was successfully implemented in a pilot-plant campaign to deliver 1.65 kg of BMS-986301 (1) and was therefore deemed suitable as a long-term option for commercial synthesis.

Authors

Publication Details

Journal
Organic Process Research & Development
Published
2026-10-05
DOI
https://doi.org/10.1021/acs.oprd.6c00219
Primary Topic
Organophosphorus compounds synthesis
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Development of a Stereoselective Route for Kilogram-Scale Synthesis of STING Agonist BMS-986301

Weiqing Fu, Melda Sezen-Edmonds, Benjamin J. Hritzko, Brian Lingfeng He et al.
Organic Process Research & Development
Organophosphorus compounds synthesis
article

Development of a Stereoselective Route for Kilogram-Scale Synthesis of STING Agonist BMS-986301

Weiqing Fu, Melda Sezen-Edmonds, Benjamin J. Hritzko, Brian Lingfeng He, Sloan Ayers, Guanghui Zhu, Geoffrey E. Purdum, Benjamin M. Cohen, Chao Hang, Daniel S. Treitler, Carlos A. Pons Siepermann, Adam J. Freitag, Michael A. Schmidt, Jonathan G. Shackman, Miao Yu, Siwei Guo, Changxia Yuan, Bin Zheng, Hua Chia Tai, Amanda J. Rogers, Jason Zhu, Jim Paulson, Qinggang Wang
article en

Abstract

Abstract Following the discovery of a chiral P(V) reagent to enable diastereoselective synthesis of stereogenic thiophosphoramidates, we have developed a scalable synthesis to deliver kilogram quantities of the STING agonist BMS-986301. The route not only reduced the number of steps compared to the enabling route but also avoided the use of hazardous reagents. Further development enabled the use of crystallizations to isolate intermediates, effectively eliminating six chromatographic purifications. This resulted in an eightfold improvement in yield and 90% reduction in process mass intensity (PMI). The route was successfully implemented in a pilot-plant campaign to deliver 1.65 kg of BMS-986301 (1) and was therefore deemed suitable as a long-term option for commercial synthesis.

Organic Process Research & Development
Openalex Percentile: Top 24%
Organophosphorus compounds synthesis
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.